NOP56 and diffuse large B-cell lymphoma: The expression of NOP56 is significantly upregulated in acute myeloid leukemia, diffuse large B-cell lymphoma, and Myc-mutant Burkitt’s lymphoma, and may also be associated with poorer prognosis (7–9).